The Queen Elizabeth Hospital (QEH) Foundation is celebrating a remarkable donor achievement: the successful completion of the ...

The following is a summary of “Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder, ureterocutaneostomy or ileal conduit: ...

Urodynamics plus comprehensive clinical assessment (CCA) is not superior to CCA only for women with refractory overactive ...

Clinical guidelines should establish clear timelines, and health care systems should prioritize timely treatment initiation and completion,” researchers concluded.

Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...

UVA Health Culpeper Medical Center’s “aquablation” procedure can offer relief for men.

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The median duration of response (DOR) exceeds 28 months and is ongoing, demonstrating the durability of cretostimogene's ...